Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040
On March 6, Bank of America raised its price recommendation on McKesson Corporation (NYSE:MCK) to $1,040 from $970. It reiterated a Buy rating on the shares.
Mckesson Corp (MCK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,376,276 | $1,128,945,440 | +7% | 0.66% |
| 2. | AQR Capital Management Cliff Asness | 918,785 | $753,670,825 | +11% | 0.4% |
| 3. | SurgoCap Partners Mala Gaonkar | 419,166 | $343,837,678 | -8% | 9.52% |
| 4. | Farallon Capital Thomas Steyer | 298,900 | $245,184,681 | -9% | 1.16% |
| 5. | GLG Partners Noam Gottesman | 218,042 | $178,857,672 | -29% | 0.3% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $144.52 | 692 | $100,006.66 | 6,843 | 2016-11-30 | Filing | |
| $136.36 | 100 | $13,635.52 | 2,005 | 2016-11-02 | Filing | |
| $136.35 | 900 | $122,715.00 | 1,905 | 2016-11-02 | Filing | |
| $156.21 | 1,000 | $156,211.40 | 1,000 | 2016-02-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $990.00 | 2,725 | $2,697,750.00 | 3,247 | 2026-03-02 | Filing | |
| $939.87 | 349 | $328,012.89 | 301 | 2026-02-19 | Filing | |
| $945.00 | 190 | $179,550.00 | 2,989 | 2026-02-17 | Filing | |
| $933.39 | 303 | $282,817.17 | 5,972 | 2026-02-11 | Filing | |
| $955.00 | 328 | $313,240.00 | 0 | 2026-02-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,625 | $1,406,210 | 0.33% | |
| 2. | 1,560 | $1,349,962 | 0.13% | |
| 3. | 1,125 | $973,530 | 0.79% | |
| 4. | 513 | $443,930 | 0.29% | |
| 5. | 283 | $244,893 | 0.08% |
News See All
14 Best American Dividend Stocks to Invest In
Investors may face periods of market volatility in 2026. Adding dividend growth stocks could help bring some stability to portfolios.
Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor
On February 18, Barclays raised its price objective on McKesson Corporation (NYSE:MCK) to $1,050 from $960. The firm reiterated an Overweight rating on the shares.
Goldman Sachs Dividend Stocks: Top 14 Stock Picks
On February 24, CNBC reported that Goldman Sachs sees the stock market as the biggest near-term risk to the US economy. The firm is less concerned about inflation or interest rates at this stage.
BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance
On February 5, 2026, BofA reaffirmed its ‘Buy’ rating on McKesson Corporation (NYSE:MCK) and increased its price target from $950 to $970.
13 Best Performing S&P 500 Stocks in the Last 5 Years
As per Reuters’ year-end report, U.S. equities ended 2025 at record highs.
McKesson's (MCK) More Powerful Than President Trump, Says Jim Cramer
McKesson Corporation (NYSE:MCK) is one of the largest healthcare services providers in America. Its shares are up by 59% over the past year and by 15% year-to-date.
12 Stocks on Jim Cramer's Radar
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer briefly commented on the Federal Reserve and interest rates.
McKesson Corporation (NYSE:MCK) Q3 2026 Earnings Call Transcript
Operator: Please stand by. Welcome to McKesson Corporation's Third Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
15 Stocks on Jim Cramer’s Recent Game Plan
Sick of earnings yet? Sorry, got another big week ahead, roughly 20% of the S&P 500. Living hell if you follow a lot of companies like I do. Fortunately, we're coming in cold.
Hedge Fund Resource Center